SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+29.68%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$236M
AUM Growth
+$236M
(+11%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
4.62%
Top 10 Holdings %
Top 10 Hldgs %
41.83%
Holding
92
New
24
Increased
26
Reduced
17
Closed
14
Top Buys
| 1 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
$7.67M |
| 2 |
Prothena Corp
PRTA
|
$6.67M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$6.51M |
| 4 |
VRAY
ViewRay, Inc.
VRAY
|
$5.79M |
| 5 |
Pliant Therapeutics
PLRX
|
$4.38M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$8.27M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$5.87M |
| 3 |
Biogen
BIIB
|
$4.25M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.13M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$3.84M |
Sector Composition
| 1 | Healthcare | 96.41% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crinetics Pharmaceuticals
CRNX
$3.26B
| $2.93M | 0.99% |
149,027
+9,488
| +7% | +$186K |
|
27
Regenxbio
RGNX
$498M
| $2.91M | 0.98% |
110,085
+5,956
| +6% | +$157K |
|
28
Cullinan Oncology
CGEM
$456M
| $2.88M | 0.97% |
224,555
+11,465
| +5% | +$147K |
|
29
CVRx
CVRX
$204M
| $2.87M | 0.97% |
307,920
+15,775
| +5% | +$147K |
|
30
LAVA Therapeutics
LVTX
$41.3M
| $2.79M | 0.94% |
+610,809
| New | +$2.79M |
|
|
ALLK
31
DELISTED
Allakos
ALLK
| $2.45M | 0.83% |
+400,000
| New | +$2.45M |
|
32
Seres Therapeutics
MCRB
$162M
| $2.35M | 0.8% |
366,493
+18,732
| +5% | +$120K |
|
33
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.35M | 0.8% |
186,603
+133,082
| +249% | +$1.68M |
|
|
KRTX
34
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.32M | 0.79% |
+10,323
| New | +$2.32M |
|
|
PNT
35
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.32M | 0.78% |
+300,000
| New | +$2.32M |
|
36
United Therapeutics
UTHR
$17.7B
| $2.24M | 0.76% |
10,696
-5,531
| -34% | -$1.16M |
|
37
Phreesia
PHR
$1.81B
| $2.12M | 0.72% |
83,305
+5,194
| +7% | +$132K |
|
38
Esperion Therapeutics
ESPR
$490M
| $2.1M | 0.71% |
+314,095
| New | +$2.1M |
|
|
IMGN
39
DELISTED
Immunogen Inc
IMGN
| $2.1M | 0.71% |
438,695
+22,216
| +5% | +$106K |
|
40
Arvinas
ARVN
$580M
| $1.81M | 0.61% |
+40,741
| New | +$1.81M |
|
41
Intellia Therapeutics
NTLA
$1.26B
| $1.79M | 0.61% |
+32,011
| New | +$1.79M |
|
42
Immunovant
IMVT
$2.91B
| $1.67M | 0.57% |
+300,000
| New | +$1.67M |
|
43
Immatics
IMTX
$662M
| $1.64M | 0.55% |
163,938
-191,165
| -54% | -$1.91M |
|
44
BioAtla
BCAB
$28.7M
| $1.54M | 0.52% |
+200,422
| New | +$1.54M |
|
45
Celldex Therapeutics
CLDX
$1.57B
| $1.5M | 0.51% |
53,275
+16,953
| +47% | +$477K |
|
|
SGEN
46
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.45M | 0.49% |
10,627
-30,160
| -74% | -$4.13M |
|
47
89bio
ETNB
$1.37B
| $1.45M | 0.49% |
+250,000
| New | +$1.45M |
|
48
Trevi Therapeutics
TRVI
$871M
| $1.45M | 0.49% |
+939,265
| New | +$1.45M |
|
|
AMYT
49
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $1.3M | 0.44% |
188,300
+11,991
| +7% | +$83K |
|
|
CLYM
50
Climb Bio, Inc. Common Stock
CLYM
$165M
| $1.3M | 0.44% |
402,088
-310,921
| -44% | -$1M |
|